TABLE 2

PET Data from Healthy Control Subjects and DCM Patients

GroupMBF* (mL/min/mL)MBFcorrATF (mL/mL)PTF (mL/mL)PTI
Control
    Anterior0.89 ± 0.201.14 ± 0.230.55 ± 0.070.57 ± 0.071.05 ± 0.16
    Lateral0.91 ± 0.181.16 ± 0.160.55 ± 0.060.63 ± 0.04†1.13 ± 0.11
    Septal0.95 ± 0.251.20 ± 0.230.52 ± 0.070.59 ± 0.081.13 ± 0.13
    Mean ± SD0.92 ± 0.201.17 ± 0.190.54 ± 0.060.61 ± 0.051.12 ± 0.10
    P (ANOVA)NSNSNS<0.05NS
DCM
    Anterior1.07 ± 0.421.32 ± 0.640.62 ± 0.060.52 ± 0.080.84 ± 0.13
    Lateral1.14 ± 0.361.39 ± 0.400.62 ± 0.060.60 ± 0.06‡0.95 ± 0.15§
    Septal0.85 ± 0.331.03 ± 0.400.58 ± 0.080.49 ± 0.120.84 ± 0.19
    Mean ± SD1.02 ± 0.341.24 ± 0.420.61 ± 0.060.55 ± 0.080.91 ± 0.12
    P (ANOVA)NSNSNS<0.01<0.05

  • ↵* mL/min/mL of perfusable tissue.

  • ↵† P < 0.05 vs. anterior.

  • ↵‡ P < 0.01 vs. septal.

  • ↵§ P < 0.05 vs. anterior and septal.

  • MBFcorr = MBF corrected for rate–pressure product; NS = not significant.